Subject(s)
Coronavirus Infections , Dementia/nursing , Family , Feeding Behavior/psychology , Long-Term Care , Malnutrition/prevention & control , Pandemics , Pneumonia, Viral , Social Isolation , Aged , Aged, 80 and over , COVID-19 , Coronavirus Infections/prevention & control , Female , Humans , Male , Pandemics/prevention & control , Pneumonia, Viral/prevention & controlSubject(s)
Alzheimer Disease/physiopathology , Coronavirus Infections , Pandemics , Pneumonia, Viral , Social Isolation , Symptom Flare Up , Aged , Aged, 80 and over , Alzheimer Disease/drug therapy , Alzheimer Disease/psychology , COVID-19 , Coronavirus Infections/prevention & control , Female , Humans , Infection Control , Male , Pandemics/prevention & control , Pneumonia, Viral/prevention & controlSubject(s)
Quality Improvement , Terminal Care/standards , Aged, 80 and over , Female , Hospice Care , Humans , Male , Nursing HomesABSTRACT
BACKGROUND: Data on the outcomes of older adults receiving peritoneal dialysis (PD), especially those who are dependent and have multiple comorbidities, are scarce. METHODS: In a retrospective cohort study, we compared older adults (≥65 years) with stage 5 chronic kidney disease receiving PD (PD group) with those receiving conservative management (conservative group). Baseline characteristics (demographics and clinical, functional, socioeconomic, and laboratory parameters) were collected, and study outcomes (patient survival, emergency hospitalization, institutionalization, and palliative and end-of-life care) were compared between groups. RESULTS: We included 199 eligible participants aged 65-90 years (mean ± standard deviation 73.8 ± 5.4 years; 157 in the PD group and 42 in the conservative group). The PD group had a longer survival (median [interquartile range]: 3.75 [2.49-5.25] vs 2.35 [1.13-3.71] years, p < .001), lower emergency hospitalization rates (1.63 [0.82-2.92] vs 3.51 [1.06-7.16] per person-year, p < .01) and hospital days (16.17 [6.29-43.32] vs 38.01 [6.75-76.56] days per person-year, p = .03), and no increased risk of institutionalization compared with the conservative group. Age (hazard ratio [HR] for 1-year increase 1.06, 95% confidence interval [CI] 1.02-1.10), modified Charlson's Comorbidity Index (HR 1.36, 95% CI 1.18-1.56), impairment in basic activities of daily living (HR 2.11, 95% CI 1.28-3.46), and emergency dialysis (HR 1.67, 95% CI 1.11-2.53) were independent predictors of mortality in the PD group. CONCLUSION: PD is a viable treatment option in older adults with stage 5 chronic kidney disease. Age alone should not preclude dialysis. Comprehensive geriatric assessment can prognosticate and facilitate shared decision making to commence dialysis in older adults.
